Related Experiment Video
Updated: Aug 4, 2026

07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Short- and intermediate-term carcinogenicity testing--a review. Part 2: available experimental models
H Enzmann1, M Iatropoulos, K D Brunnemann
1Bayer AG, Institute of Toxicology, Wuppertal, Germany.
Summary
This review explores short- and intermediate-term carcinogenicity assays in various species, focusing on rodent multi-organ models and alternative systems. It discusses assay validation and proposes a strategy for chemical safety assessment regarding carcinogenicity detection.
Area of Science:
- Toxicology
- Carcinogenesis
- Chemical Safety Assessment
Background:
- Established short- and intermediate-term carcinogenicity assays exist for many years.
- Previous review part introduced mouse skin tumour and rat liver foci assays.
- This part focuses on rodent assays for multiple target organs and alternative species.
Purpose of the Study:
- To survey diverse short- and intermediate-term carcinogenicity test systems.
- To detail rodent assays for various organs and multi-organ models.
- To outline and discuss fish, non-vertebrate, and avian embryo assays for carcinogenicity testing.
Main Methods:
- Review of existing experimental protocols for carcinogenicity assays.
- Focus on rodent assays for lung, kidney, urinary bladder, pancreas, stomach, oral cavity, small intestine, and colon.
- Inclusion of multi-organ models and alternative species (fish, non-vertebrates, avian embryos).
Main Results:
- Detailed examination of rodent assays for specific target organs and multi-organ approaches.
- Assessment of the potential use, advantages, and limitations of fish, non-vertebrate, and avian embryo assays.
- Discussion on the validation challenges of carcinogenicity test systems.
Conclusions:
- A comprehensive overview of short- and intermediate-term carcinogenicity assays is presented.
- The review highlights the utility of rodent multi-organ models and alternative species.
- A strategy for contemporary chemical safety assessment concerning carcinogenicity detection and evaluation is proposed.
More Related Videos
Related Concept Videos
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
